LGBT discrimination in healthcare means unequal treatment because of someone’s sexual orientation or gender identity. It can involve refusing care, dismissing symptoms, excluding a partner or making assumptions that leave someone without appropriate screening. The consequences reach beyond an uncomfortable appointment: people need care they can use without hiding who they are.
Originally published on 21 May 2019 by Madison Salters, an Uncomfortable Revolution Writing Fellow. Revised and updated by Brendan McDonald on 17 September 2026 to update medical information, incorporate newer research, and update the legal context. Madison’s original authorship is retained.
Everyone needs medical care. What happens when a doctor assumes a lesbian patient doesn’t need cervical screening? When an asexual patient isn’t believed about their sexual history? When a partner arrives at a hospice and is treated as “just a friend”?
These are different situations, with different clinical and personal consequences. There’s no single LGBTQIA+ healthcare experience. Sexual orientation, gender identity and variations in sex characteristics aren’t interchangeable, and none tells a clinician everything they need to know about a patient’s body or health.
This article looks at ordinary healthcare as well as cancer screening and end-of-life care. Disabled and chronically ill LGBTQIA+ people belong in that conversation throughout, rather than being treated as an afterthought.
What does LGBT discrimination in healthcare look like?
A clinic can have a rainbow sticker on its door and still ask questions that assume every patient is heterosexual. A form can offer space for a spouse but no useful way to record the person a patient actually relies on. An appointment can become a discussion about someone’s identity while the symptoms they came in with go unaddressed.
These examples describe problems a service should examine, not a claim that every awkward interaction has the same cause. Clinicians may need to ask about anatomy, medication or sexual activity. The question is whether they explain why, respect the answer and use it to provide relevant care.
There is documented evidence of discrimination. In a June 2023 American Cancer Society Cancer Action Network survey, 37% of LGBTQ+ cancer patients and survivors surveyed reported discrimination in healthcare because of their sexual orientation or gender identity. Among those reporting discrimination, 75% said it negatively affected their care. Those figures describe that survey’s respondents, not every LGBTQ+ person or every healthcare service.
For someone who needs repeated appointments, trust matters every time. A useful starting point for a clinician is to ask what the patient needs, rather than deciding in advance which parts of their life are relevant. URevolution’s Healthcare & Medical Power section examines that relationship between patients, clinicians and the systems around them.
LGBTQ+ cancer care: being seen, but not screened
Screening looks for disease or precancerous changes before symptoms appear. Investigating a symptom is a different task. Someone who isn’t due for routine screening can still need assessment for a new lump, unexplained bleeding or another concerning change.
A study published in Cancer on 6 July 2026 analysed US survey data collected from 2018 to 2022. It found lower uptake of some breast and cervical screening among sexual- and gender-minority groups. The researchers did not find a significant difference in overall cancer prevalence between the groups they compared.
That distinction matters. A screening gap is not proof that every LGBTQ+ person has a higher cancer risk. Nor does a paper published in 2026 mean the underlying survey describes appointments taking place in 2026.
Cervical screening is not determined by a partner’s gender
A lesbian or bisexual identity does not rule out exposure to human papillomavirus, or HPV. The Australian STI Management Guidelines recommend cervical screening for eligible people with a cervix who have sex with women, according to national screening guidance.
The practical question is which guidance applies to your age, anatomy and medical history. Screening schedules and tests vary by country. Ask a clinician to explain the recommendation rather than accepting the assumption that not having sex with men means screening is unnecessary. You can also ask about HPV vaccination and ways to make an examination more manageable.
Breast screening needs an individual assessment
The same 2026 study found differences in breast-screening uptake. It does not support telling every lesbian or bisexual woman that she has two or three times someone else’s breast-cancer risk.
Ask which screening programme or clinical guidance applies to you and what information the clinician needs to make that decision. For trans patients, that conversation should include relevant hormone treatment and surgery history. A gender marker in a record should not replace a clinical assessment.
Ovarian cancer: more screening is not always better care
Routine ovarian-cancer screening is not recommended for asymptomatic people at average risk. The US Preventive Services Task Force recommendation explains that screening with CA-125 blood tests or transvaginal ultrasound does not reduce ovarian-cancer deaths in this group and can lead to harm from false-positive results and unnecessary surgery.
A Pap test is not an ovarian-cancer screening test. Persistent symptoms and a family history suggesting hereditary cancer risk need their own discussion with a clinician. Neither should be brushed aside because of sexuality, and neither is a reason to recommend annual ovarian screening to everyone.
Transgender healthcare and hormone therapy: ask about the actual body
A trans person may need care entirely unrelated to transition. They should not have to turn every appointment into a lesson about their identity before anyone addresses the reason they came.
When screening or treatment does depend on anatomy, clinicians need an accurate, sensitively obtained history. That means discussing relevant organs, previous procedures and current medication without assuming that a gender label supplies the answers. Explain the clinical purpose of a question. Ask permission before an examination. Use the patient’s name and pronouns.
Older versions of this article overstated some hormone-related cancer risks. UCSF’s transgender-care guidance on ovarian cancer states that there is no evidence that testosterone increases ovarian-cancer risk. It does not recommend routine ovarian screening simply because someone uses testosterone.
One practical distinction is essential: testosterone is not contraception. Pregnancy can still be possible for someone with the relevant reproductive organs, even if periods have stopped. A clinician should discuss contraception when pregnancy is possible and unwanted, without making assumptions about partners or sexual activity.
Hormone prescriptions and monitoring require individual medical care. This article does not recommend a dose, a particular route of administration, or stopping treatment. Questions about symptoms, side effects, fertility or screening belong in a conversation with a clinician familiar with the patient’s treatment and health history.
Disability, chronic illness and mental health belong in the same conversation
A wheelchair-accessible entrance does not answer every access need. Ask whether appointment letters are understandable, whether someone can bring their chosen support person, and whether the consultation allows enough time to communicate. Sexuality should not disappear from the conversation when a patient is disabled. Neither should disability disappear when the conversation concerns LGBTQ+ healthcare.
Australian research published on 13 August 2026 found differences in psychological distress, mental disorders and functional difficulties between cisgender heterosexual participants and sexual- and gender-minority groups. It analysed the 2020–2022 National Study of Mental Health and Wellbeing, not a new 2026 survey.
The study was cross-sectional and included a relatively small transgender sample. It cannot establish that healthcare discrimination caused those differences. Nor should group averages be used to treat an LGBTQ+ identity as an illness or assume an individual is disabled.
For readers who recognise the experience of having their account of illness dismissed, URevolution also publishes a personal account of medical gaslighting. A contributor’s experience can help name a problem without becoming a diagnosis or a substitute for medical assessment.
LGBTQ+ palliative and end-of-life care: who matters to you?
What does end-of-life care look like if you’re gay? Who gets recognised as your partner? Who is invited into a conversation, and who is left standing outside it?
Palliative care addresses physical, psychological, social and spiritual needs associated with life-threatening illness. It can begin before someone’s final days. LGBTQ+ patients need the same attention to comfort and support, with care that takes their relationships seriously.
In its 2016 report on LGBT end-of-life care, Marie Curie documented concerns about assumptions, disclosure and the recognition of partners. One participant said:
“But on my own, I just don’t feel I can join in.”
That is a historical account, not a measure of every hospice today. It still poses a useful question for care teams: is a patient able to talk about their life without first working out whether their relationships will be accepted?
Ask who the patient’s important people are. Use the names and relationship terms they give you. Do not assume that biological relatives are the people they want involved, or that an apparently heterosexual relationship tells you someone’s sexuality. Discuss how private information will be recorded and shared, including what the patient wants kept from visitors.
Chosen family matters, but an informal relationship label does not settle who can legally make medical decisions. In the US, the National Institute on Aging explains how to choose and formally appoint a healthcare proxy. Requirements vary by state. Elsewhere, ask about the equivalent local process. Record care preferences and check that the relevant people and healthcare team have the documents they need.
Some people also choose non-medical support when thinking about death and dying. URevolution’s article on the role of a death doula explores that kind of support; it does not replace palliative medicine or legal planning.
Intersex and asexual patients: listen before making assumptions
Intersex patients need information and involvement in their care
Intersex is an umbrella term for variations in sex characteristics. It does not tell a clinician someone’s gender identity, sexuality or specific healthcare needs.
Patients deserve clear explanations of their medical history, test results and proposed treatment. A clinician should explain why an intervention is being considered, what alternatives exist and how the patient can participate in decisions. Unfamiliar anatomy is not a reason to abandon privacy, consent or ordinary respect.
The earlier version’s broad claims about congenital adrenal hyperplasia and intersex development have been removed. Different variations have different clinical implications; a general magazine article should not collapse them into a single account of risk, puberty or treatment.
Asexuality is not something a clinician needs to fix
The American Association of Sexuality Educators, Counselors and Therapists states that asexual and ace-spectrum identities are not mental, developmental or sexual disorders. Asexuality concerns sexual attraction; it should not be treated as a diagnosis.
A patient may want help with a change in desire, pain or a medication effect. Another may be comfortable with their sexuality and want care for something entirely different. Listen to what the patient is asking for. Do not presume that an asexual person’s lack of interest in sex is a problem they want treated, or that their account of sexual activity is untrue.
Appropriate screening and symptom assessment still require an individual history. Neither assuming that every asexual person is sexually active nor assuming that none is sexually active is a useful substitute for asking.
Healthcare rights: a US update as of September 2026
Legal protection depends on the jurisdiction, the service and the conduct involved. Older versions of this article discussed US court decisions and federal rules as though their implications were settled. That is not a reliable guide to a person’s current legal options.
In a notice published on 2 June 2026, the US Department of Health and Human Services recognised an October 2025 court decision vacating certain gender-identity-related provisions of its 2024 Section 1557 rule. The notice states that the rule’s remaining provisions remain in force.
That notice does not, by itself, answer whether a particular incident violates federal or state law. Anyone considering a complaint should check the current rules with a qualified local adviser or the relevant civil-rights or health-complaints body. This article is not legal advice.
What better care should involve
Patients should not have to become experts in discrimination law or clinical guidelines to get through an appointment. These questions may help a conversation, but responsibility for appropriate care remains with the service:
Four questions for a healthcare appointment
Your care
Which screening or treatment guidance applies to my medical history, and why? What is the plan for the symptoms I came in with?
Consent and privacy
Why is this information needed? Who can see it? What are my options for an examination or for having someone with me?
Access and support
What communication or access arrangements can we make, and how will my chosen support person be involved?
The next step
Who can explain a decision, help resolve a concern or arrange another clinical opinion?
You don’t have to ask perfectly to deserve appropriate care.
AI-generated editorial illustrations of fictional scenes.
Where it is safe and useful, keeping appointment notes and asking for an explanation in writing can make a concern easier to follow up. A service’s patient liaison or complaints team may help explain its process. You do not have to disclose more of your identity in a public complaint than you are comfortable sharing.
The core question is straightforward: did the patient receive care for the person and the health needs in front of the clinician, or for a set of assumptions? Every service should be willing to examine its answer.
This article provides general information, not individual medical advice. Screening and treatment decisions should follow current local guidance and a clinician’s assessment of your circumstances.
Feature image: AI-generated editorial illustration of a fictional scene.
